Del Labs Q2
This article was originally published in The Rose Sheet
Executive SummarySecond quarter net sales increased 5.1% to $98 mil. fueled by Sally Hansen, which maintained its number one position in the mass market nail category in the period, and the launch of Healing Beauty cosmetics, the company reports July 29. Net earnings were up 7.6% to $4.9 mil. including an after-tax charge of $1.2 mil. related to severance costs associated with the relocation of the company's manufacturing operations. Relocation to Rocky Point, N.C. from Farmingdale, N.Y. will consolidate manufacturing operations with distribution facility and result in improved operating efficiencies and reduced manufacturing expenses, Del Labs says. Corporate headquarters will remain in Uniondale, N.Y...
You may also be interested in...
Consultant John McKay encourages device makers to ask questions of the US FDA’s inspection team during a facility audit. Check out his advice here.
ICER president Steve Pearson is ‘cautiously optimistic’ that net pricing for acute migraine treatments will align with benefits once discounts are factored in.
Almost 50 novel agents are already under review at FDA for potential 2020 approval. Candidates are notably diverse, with concentrations in established strongholds (oncology, neuroscience), popular programs (breakthrough), and powerhouse sponsors (keep an eye on Bristol-Myers Squibb right out of the gate).